Most CMC programs that fail at the GMP stage do not fail because of chemistry.
They fail because the transfer was incomplete. A process parameter implicitly controlled in the lab was not formally documented. A method worked fine on development equipment but was not qualified on the CDMO’s instruments. A raw material specification was assumed, not written down.
Technology transfer from lab to GMP is a structured program with discrete stages, each requiring documented evidence before the next begins. When CMC teams treat it as a handoff, every gap the CDMO finds becomes a surprise.
Why Technology Transfers Fail
The most common causes are not technical. They are organizational.
- The originating lab holds tacit knowledge that never made it into the batch record
- CPPs were identified informally but never assigned operating ranges or limits
- Analytical methods were built for lab characterization, not for GMP release
- The quality agreement was signed after the transfer started, not before
ICH Q10 is explicit: the goal of technology transfer is to transfer product and process knowledge between development and manufacturing. Documents can exist without capturing the knowledge that makes a process actually work.
The Five-Stage Framework
Stage 1: Gap Assessment and Knowledge Package Audit
Before anything moves, both teams need to understand what the sending site actually has. A structured gap assessment maps:
- Defined critical quality attributes (CQAs) and the evidence base for each
- CPPs and their established operating ranges and acceptable limits
- Raw material specifications including supplier qualifications and criticality classifications
- Analytical methods and their validation status against ICH Q2(R2)
- Development history including batch failure data, out-of-specification investigations, and process deviations
Quality gate: The gap assessment closes when both teams agree on what is missing, with a documented plan to generate it and each unresolved item assigned an owner and deadline.
Stage 2: Process Documentation and Process Lock
Process lock is the formal commitment that the synthetic route and process conditions will not change without a documented change control procedure.
At lock, the following must be complete:
- Master batch record with all CPPs, their operating ranges, and in-process acceptance criteria
- Control strategy mapping which CPPs affect which CQAs and how each is controlled
- Raw material specifications signed off against the CDMO’s supplier landscape
- Impurity fate and purge analysis documenting where each impurity is generated and how it is controlled or removed
Every subsequent validation activity rests on the process described here. A batch record requiring correction mid-validation introduces a change control event that delays the GMP batch.
Quality gate: The CDMO’s QA team and the sponsor’s CMC lead formally approve the master batch record before the engineering run is scheduled.
Stage 3: Analytical Method Transfer
Analytical method transfer must be completed before the CDMO’s QC laboratory generates any data used in a GMP batch release. The formal transfer protocol defines:
- The methods being transferred and their current validation status
- Sending and receiving lab comparison experiments and which samples each analyzes
- Pre-defined acceptance criteria for equivalence, typically precision, accuracy, and specificity from ICH Q2(R2) validation data
- Instrument suitability confirmation at the receiving site
Standard physicochemical methods transfer within weeks when the method is well developed. Complex stability-indicating methods or those with unusual system suitability requirements can take significantly longer.
Quality gate: Transfer closes with a formal report documenting pass or fail against each acceptance criterion. Methods that do not pass require root cause investigation before GMP release use begins.
Stage 4: Engineering Run
An engineering run is a non-GMP manufacturing run using the locked process, transferred analytical methods, and site equipment. It tests the gap between what the batch record describes and what the CDMO’s equipment and personnel actually produce.
Engineering runs routinely surface:
- Equipment scale and geometry effects not captured in lab-scale development
- Mixing, heat transfer, or filtration differences between lab and plant
- Raw material lot-to-lot variability masked at small scale
- Operator interpretation gaps in the batch record
Deviations trigger process adjustments and change control documentation, and, if significant, a second engineering run.
Stage 5: GMP Validation Batches and Validation Report
Process validation confirms that the manufacturing process consistently delivers product meeting its predetermined specifications.
For early clinical supply, the validation package typically covers:
- A minimum of three GMP batches at the intended scale demonstrating reproducibility across CPPs and CQAs
- In-process controls data showing CPPs within their established ranges for each batch
- Release testing data against the approved specification using the transferred analytical methods
- A process validation report covering the complete manufacturing and analytical history
Quality gate: The process validation report is reviewed and approved by both CDMO and sponsor QA before the batch is released for clinical use.
How LAXAI Structures Technology Transfer
LAXAI’s CMC technology transfer workflow maps to this five-stage framework, with formal quality gates documented before each new stage opens.
Because process chemistry and analytical development operate within the same organization, the Stage 1 gap assessment draws on the same team that built the process. CPPs were established during development, not reconstructed for the transfer. Analytical methods from the development lab move directly into the GMP QC laboratory, reducing transfer workload significantly.
LAXAI’s project teams include dedicated CMC regulatory support, so batch records and control strategy documentation are built to IND or IMPD submission standards from the start of the transfer.
Contact LAXAI’s CMC team to discuss your technology transfer timeline at bd@laxai.com
FAQs
What is the difference between a process lock and process validation? Process lock fixes the synthetic route and process conditions, documented in the master batch record. Process validation is the subsequent experimental confirmation that the locked process consistently delivers product meeting its specifications.
What does a quality gate mean in a technology transfer? A formally documented review checkpoint that must be completed before the next stage begins. It ensures gaps or failures at one stage are resolved before resources are committed to the next.
How long does analytical method transfer take? Standard physicochemical methods can transfer in two to four weeks. Stability-indicating methods or those requiring instrument qualification at the receiving site can take significantly longer, depending on complexity and validation status at the time of transfer.
When should a CMC team start the technology transfer process? Before GMP batch scheduling is confirmed. The gap assessment and process lock stages require time that is often underestimated, and compressing them against a fixed batch date is the most common cause of transfer delays.
